Anti-IL-17 monclonal antibody ixekizumab effect on chronic psoriasis - - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Full record GDS4458

Anti-IL-17 monclonal antibody ixekizumab effect on chronic psoriasis

Analysis of psoriatic skin biopsies from patients treated with 150mg of subcutaneous anti-IL-17 mAb ixekizumab (previously LY2439821) at weeks 0 and 2. IL-17 blockade resulted in a high-grade clinical improvement in psoriasis. Results provide insight into the role of IL-17 in disease pathogenesis.

Organism:: Homo sapiens

Type:: Expression profiling by array, transformed count, 2 agent, 17 individual, 2 time sets

Platform:: GPL571
Series:: GSE31652
30 Samples

Download data: CEL

DataSet

Accession:: GDS4458

ID:: 4458

PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet

Supplemental Content

Related information

PubMed
Related PubMed entries
Full text in PMC
PMC links
Similar studies
Similar studies
GEO Profiles
Related GEO
BioProject
BioProject links
GEO DataSets
Related GEO DataSets
Taxonomy
Taxonomy

Important Links

Recent activity

Clear Turn Off Turn On

Anti-IL-17 monclonal antibody ixekizumab effect on chronic psoriasis
Anti-IL-17 monclonal antibody ixekizumab effect on chronic psoriasis
Accession: GDS4458

GEO DataSets
Related DataSets for GEO Profiles (Select 93162723) (1)
GEO DataSets

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets